The list price is $373,000, the same as Gilead's other CAR-T therapy.
Investors Should Avoid Getting Burned by Complex ETFs
Although returns may appear lucrative, many will not even recoup their initial investment in these exotic ETFs.
In Similar Category
Kitco News reports on U.S. sales of new homes for March
Global stock markets enjoyed cautious gains on Friday, taking their cue from Wall Street tech shares, but tepid economic data and lofty valuations rei...
Publix is announcing a recall of some salads sold in its stores.
Retail was hit the worst. The review site has also seen a spike in searches for Black-owned businesses.
Goldman Sachs says S&P 500 earnings will plunge 60% this quarter, the biggest decline since 2009
From Motley Fool
David Klein says that federal legalization is on its way no matter who wins in November.
It's time to prep your portfolio for the next market downturn.
By acting now, the Israeli Health Ministry says it's avoiding long delays in getting the country's citizens a COVID-19 vaccine later.
The new week got off to a good start.
Cruise-line stocks faced a deluge of Wall Street downgrades and other negative developments, but they didn't all move lower this week.